期刊文献+

比浊法C-反应蛋白水平对慢性阻塞性肺疾病急性加重未见预测价值 被引量:1

Effectiveness of turbidity method C-reaction protein in prognosis for acute exacerbation of chronic obstructive pulmonary disease
原文传递
导出
摘要 目的探讨血清C-反应蛋白(CRP)水平对慢性阻塞性肺疾病(COPD)是否出现急性加重的预测价值。方法65例COPD患者为研究对象,用免疫透射比浊法测定其就诊次日清晨静脉血的CRP水平,患者按CRP水平分为CRP阳性组(CRP≥8mg/L,34例)和CRP阴性组(cRP〈8mg/L,31例),随后追踪观察两组1年内COPD急性加重例数并进行比较。结果经回顾性分析,CRP阳性组有21例,CRP阴性组有14例在1年内出现COPD急性加重。经x。检验,两组1年内出现COPD急性加重率差异无统计学意义(P〉0.05)。结论用免疫透射比浊法测定就诊次日清晨静脉血的血清CRP水平对COPD患者在1年内是否出现急性加重未能见到预测价值。 Objective To assess the effectiveness of serum C-reactive protein(CRP) in the prognosis of the acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods Sixty-five patients with COPD were taken as study subjects. Their serum CRP concentration was measured on the second day of hospitalization. According to the CRP levels measured,the study subjects were divided into two groups,CRP positive group (CRP≥8 mg/L,34 cases)and CRP negative group (CRP〈8 mg/L,31 cases). In the subsequent one year, the two groups were observed and compared in terms of the instances of the acute exacerbation of COPD. Results According to the retrospective observation,in the duration of one year,there were 21 cases of acute exacerbation of COPD in CRP positive group and 14 cases in CRP negative group. The difference in acute exacerbation between two groups is insignificant ( P 〉 0.05 ). Conclusions The initial measurement of serum CRP concentration in the COPD patients by the immunity-turbidity method (on the second clay of hospitalization) has proven to be ineffective in the prognosis for acute exacerbation of COPD in one year.
出处 《国际呼吸杂志》 2008年第7期389-390,共2页 International Journal of Respiration
关键词 C-反应蛋白 慢性阻塞性肺疾病 预测 C-reactive protein Chronic obstructive pulmonary disease Prognosis
  • 相关文献

参考文献6

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin lnvest, 2003,111 : 1805-1812.
  • 3Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest, 2003,123 : 2043-2049.
  • 4Dev D,Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med, 1998,92 : 664-667.
  • 5Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2007,175 : 250-255.
  • 6Donaldson GC. C-reactive protein:does it predict mortality? Am J Respir Crit Care Med,2007,175:209-210.

共引文献5102

同被引文献9

  • 1National Heart,Lung and Blood Institute.Morbidity and MortalityChartbook. . 2000
  • 2Wedzicha JA,Syndercombe-Court D,Tan KC.Increased plateletaggregate formation in patients with chronic airflow obstruction andhypoxaemia. Thorax . 1991
  • 3GC Donaldson,TA Seemungal,IS Patel.Airway and systemic inflammation and decline in lung function in patients with COPD. Chest . 2005
  • 4Pinto-Plata VM,Livnat G,Girish M,et al.Systemic cytokines,clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest . 2007
  • 5Gan WQ,Man SF,Senthilselvan A,et al.Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax . 2004
  • 6Schols A M,Buurman W A,Staal-van den Brekel A J,et al.Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax . 1996
  • 7Fabbri LM,Ferrari R.Chronic disease in the elderly:back to the future of internal medicine. Breathe . 2006
  • 8徐斐,洪忻,沈洪兵,徐耀初.慢性阻塞性肺病不同病情患者血清C反应蛋白和磷酸肌酸激酶同工酶水平[J].中国慢性病预防与控制,2008,16(1):46-48. 被引量:2
  • 9陈凤娟,漏德宝,祁慧薇,庄远非,胡辛,张羽萍,高育瑶.C反应蛋白在老年COPD急性加重期的临床意义[J].中国临床实用医学,2009,3(7):19-20. 被引量:1

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部